Goldman Sachs Maintains Mead Johnson Nutrition CO to Neutral with Price Target $85.00

Brokerage firm Goldman Sachs Maintains its rating on Mead Johnson Nutrition CO(NYSE:MJN). In a research note issued to the investors, the brokerage major Lowers the price-target to $85.00 per share. The shares have been rated Neutral. The rating by Goldman Sachs was issued on Sep 27, 2016.

In a different note, On Sep 8, 2016, Citigroup said it Maintains its rating on Mead Johnson Nutrition CO. In the research note, the firm Lowers the price-target to $106.00 per share. The shares have been rated ‘Buy’ by the firm. UBS said it Initiates Coverage on Mead Johnson Nutrition CO, according to a research note issued on Aug 24, 2016. The shares have been rated ‘Neutral’ by the firm. On Aug 3, 2016, CLSA said it Upgrades its rating on Mead Johnson Nutrition CO. The shares have been rated ‘Outperform’ by the firm. On Jul 29, 2016, Societe Generale said it Downgrades its rating on Mead Johnson Nutrition CO. The shares have been rated ‘Hold’ by the firm. On Jul 26, 2016, JP Morgan said it Upgrades its rating on Mead Johnson Nutrition CO. The shares have been rated ‘Overweight’ by the firm. On Jul 25, 2016, Citigroup said it Maintains its rating on Mead Johnson Nutrition CO. In the research note, the firm Raises the price-target to $100.00 per share. The shares have been rated ‘Buy’ by the firm.

Mead Johnson Nutrition CO (MJN) made into the market gainers list on Fridays trading session with the shares advancing 0.98% or 0.77 points. Due to strong positive momentum, the stock ended at $79.01, which is also near the day’s high of $79.23. The stock began the session at $78.65 and the volume stood at 11,85,875 shares. The 52-week high of the shares is $94.4 and the 52 week low is $65.53. The company has a current market capitalization of $14,590 M and it has 18,46,58,800 shares in outstanding.

Mead Johnson Nutrition CO(MJN) last announced its earnings results on Jul 28, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $941.50M. Analysts had an estimated revenue of $964.56M. Earnings per share were $0.88. Analysts had estimated an EPS of $0.78.

Several Insider Transactions has been reported to the SEC. On Aug 15, 2016, Kimberly A Casiano (director) sold 710 shares at $89.75 per share price.Also, On Aug 5, 2016, Graciela Monteagudo (SVP&PresAmericas&Glob.Market’g) sold 45,873 shares at $87.69 per share price.On May 3, 2016, Christoper Richard Stratton (SVP and President, Asia) sold 33,730 shares at $86.68 per share price, according to the Form-4 filing with the securities and exchange commission.

Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas children’s milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Mead Johnson Nutrition CO - Is it time to Sell?

Top Brokerage Firms are advising their investors on Mead Johnson Nutrition CO. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.